ANIP ANI Pharmaceuticals, Inc.
$71.52 -1.46%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-1.46%
YTD
-22.00%
P/E
15.47
P/B
3.28
ROE
19.6%
Div yield
—
Beta
0.24
Market cap
$1.7B
RSI (14)
42
Next earnings
Nov 5, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$72.99
Close
$71.52
VWAP (n/a)
—
Day high
$72.99
Day low
$70.80
Volume
292K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting
Yahoo Finance · Sep 30
Implied Volatility Surging for ANI Pharmaceuticals Stock Options
Yahoo Finance · Sep 28
Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know
Yahoo Finance · Sep 23
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
Yahoo Finance · Sep 23
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
Yahoo Finance · Sep 4
2 Reasons to Like ANIP (and 1 Not So Much)
Yahoo Finance · Aug 27
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 24, 2026 View → 10-Q Aug 7, 2026 View → 8-K Aug 7, 2026 View → 8-K May 21, 2026 View → 8-K May 13, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell ANIP. Try it in the Lab to size a position and see the risk.